Alyeska Investment Group
VIVE

Alyeska Investment Group’s VIVEVE MED INC VIVE Stock Holding History

Alyeska Investment Group’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-16,300
Closed -$92K – 621
2020
Q2 		$92K Hold
16,300
– – ﹤0.01% 463
2020
Q1 		$112K Hold
16,300
– – ﹤0.01% 359
2019
Q4 		$206K Buy
+16,300
New +$463K ﹤0.01% 386

Other funds holding VIVE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
JCM
Jacobi Capital Management Pittston, Pennsylvania $2.04B AUM 26.26% 1-Year Est. Return

Alyeska Investment Group's VIVE Position: Q1 2020 in Review

Alyeska Investment Group sold out of VIVEVE MED INC (VIVE) in Q1 2020, closing a stake of 8,181 shares — an estimated $81.4K sold.

Alyeska Investment Group first reported a position in VIVE in Q1 2017 and held it in 4 quarters. The position peaked at $3.31M in Q1 2018. 11 funds tracked by Wall St. Rank hold VIVE as of Q1 2020.

  • Alyeska Investment Group reported no remaining VIVEVE MED INC position as of Q1 2020 after selling out during the quarter.
  • Alyeska Investment Group sold 8,181 VIVEVE MED INC shares in Q1 2020, an estimated $81.4K.
  • Alyeska Investment Group first reported a position in VIVEVE MED INC in Q1 2017 and held it in 4 quarters.
  • Alyeska Investment Group's VIVEVE MED INC position peaked at $3.31M in Q1 2018.
  • 11 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q1 2020.

Based on Alyeska Investment Group's 13F filing for Q1 2020, filed 15 May 2020.